Swiss will allow stem cell research
GENEVA - Swiss voters have overwhelming backed a proposal to allow stem-cell research on human embryos. The new law won the support of more than 66 per cent of voters.
The ballot makes Switzerland the first country in the world to put the controversial issue to a popular vote.
Switzerland is a world leader in medical and pharmaceutical research, but so far it has not permitted research on human embryos.
The Swiss government, universities and the pharmaceutical industry have urged support for the new law which will allow stem cell research on surplus human embryos.
The Catholic Church, the Swiss Green party and medical ethics groups all campaigned against the law, claiming that stem cell research offers false hope to people with diseases such as Alzheimer's. They suggest cloning could be Switzerland's next step.
But according to a law which the Swiss Parliament approved in 2003, cloning and the trade in embryos would continue to be banned along with research on the embryos themselves.
The production of stem cells would be limited to embryos not older than seven days.
Research would be permitted only on cells that are left over from fertilization treatment and due for destruction, and the couple involved would have to give written permission.
Written by CBC News Online staff